A detailed history of International Assets Investment Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, International Assets Investment Management, LLC holds 38,852 shares of CRSP stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,852
Holding current value
$2.02 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$44.62 - $62.75 $1.73 Million - $2.44 Million
38,852 New
38,852 $827,000
Q2 2021

Jul 14, 2021

SELL
$100.84 - $161.89 $8,067 - $12,951
-80 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$79.67 - $173.23 $6,373 - $13,858
80 New
80 $12.2 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.05B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.